BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

European Journal of Human Genetics : EJHG
Hildegunn Høberg-VettiNicoline Hoogerbrugge

Abstract

Germline BRCA1/2 testing of breast and ovarian cancer patients is growing rapidly as the result affects both treatment and cancer prevention in patients and relatives. Through the DNA-BONus study we offered BRCA1/2 testing and familial risk assessment to all new patients with breast (N=893) or ovarian (N=122) cancer diagnosed between September 2012 and April 2015, irrespective of family history or age, and without prior face-to-face genetic counselling. BRCA1/2 testing was accepted by 405 (45.4%) and 83 (68.0%) of the patients with breast or ovarian cancer, respectively. A pathogenic BRCA1/2 variant was found in 7 (1.7%) of the breast cancer patients and 19 (22.3%) of the ovarian cancer patients. In retrospect, all BRCA1/2 mutation carriers appeared to fulfill current criteria for BRCA1/2 testing. Hospital Anxiety and Depression Scale (HADS) scores showed that the mean levels of anxiety and depression were comparable to those reported for breast and gynecological cancer patients in general, with a significant drop in anxiety symptoms during a 6-month follow-up period, during which the test result was forwarded to the patients. These results show that BRCA1/2 testing is well accepted in newly diagnosed breast and ovarian cancer ...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Feb 8, 2002·Journal of Psychosomatic Research·Ingvar BjellandDag Neckelmann
Feb 26, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R RebbeckBarbara L Weber
Apr 7, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc D SchwartzClaudine Isaacs
Jun 19, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pål MøllerAnita Vabø
Oct 28, 2008·Human Mutation·Sharon E PlonUNKNOWN IARC Unclassified Genetic Variants Working Group
Jan 15, 2009·Journal of the National Cancer Institute·Timothy R RebbeckSusan M Domchek
Oct 21, 2009·Current Opinion in Obstetrics & Gynecology·Allison W Kurian
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Iris van Oostrom, Aad Tibben
Jun 20, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn AlsopGillian Mitchell
Jun 30, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eveline A M HeijnsdijkHarry J de Koning
Aug 15, 2012·Journal of Medical Genetics·Amanda B SpurdleUNKNOWN ENIGMA Consortium
Oct 12, 2012·Social Psychiatry and Psychiatric Epidemiology·Audun BrunesSigridur Lara Gudmundsdottir
May 1, 2013·Journal of the National Cancer Institute·Nasim MavaddatUNKNOWN EMBRACE
Nov 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-M LeeE C Kohn
Nov 20, 2013·Breast Cancer Research and Treatment·Sarah L InghamD Gareth R Evans
Apr 2, 2014·Breast Cancer Research and Treatment·D Gareth EvansDuffy Stephen
Sep 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aisha S SieNicoline Hoogerbrugge
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching

❮ Previous
Next ❯

Citations

Jul 26, 2018·Journal of Medical Genetics·Jeanna M McCuaigUNKNOWN BRCA TtoT Community of Practice
Aug 16, 2016·European Journal of Human Genetics : EJHG·Nicoline Hoogerbrugge, Marjolijn Cj Jongmans
Jun 18, 2020·Journal of Clinical Medicine·Neil Aj RyanEmma J Crosbie
Oct 13, 2018·Breast Cancer Research and Treatment·Martin P NilssonNiklas Loman
Apr 4, 2018·Breast Cancer Research and Treatment·Marc D SchwartzKatia Khoury
Jun 8, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Martin P NilssonNiklas Loman
Oct 7, 2016·Medicine, Health Care, and Philosophy·Kari Nyheim SolbrækkeBirgitta Haga Gripsrud
Mar 24, 2020·European Journal of Human Genetics : EJHG·Hildegunn Høberg-VettiPer Morten Knappskog
Feb 25, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Stephanie A KraftSandra Soo-Jin Lee
Jun 5, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karen A GelmonUNKNOWN Collaborating Investigators
Jul 15, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jada G HamiltonSusan M Domchek

❮ Previous
Next ❯

Methods Mentioned

BETA
prophylactic surgery

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.